Dermatitis herpetiformis future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Dermatitis herpetiformis}} | {{Dermatitis herpetiformis}} | ||
{{CMG}} | {{CMG}} | ||
| Line 11: | Line 11: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category:Allergology]] | [[Category:Allergology]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Skin diseases]] | [[Category:Skin diseases]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Revision as of 21:17, 29 July 2020
|
Dermatitis herpetiformis Microchapters |
|
Differentiating Dermatitis herpetiformis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Dermatitis herpetiformis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Dermatitis herpetiformis future or investigational therapies |
|
FDA on Dermatitis herpetiformis future or investigational therapies |
|
CDC on Dermatitis herpetiformis future or investigational therapies |
|
Dermatitis herpetiformis future or investigational therapies in the news |
|
Blogs on Dermatitis herpetiformis future or investigational therapies |
|
Risk calculators and risk factors for Dermatitis herpetiformis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]